Fondaparinux: another potential treatment for heparin-induced thrombocytopenia type II?

Ítems similars

• Presepsin and sepsis-induced acute kidney injury treated with continuous renal replacement therapy: will another promising biomarker bite the dust?
  per: Honore, Patrick M., et al.
  Publicat: (2015)
• Meropenem therapy in extracorporeal membrane oxygenation patients: an ongoing pharmacokinetic challenge
  per: Honore, Patrick M., et al.
  Publicat: (2015)
• ‘Biomarking’ infection during continuous renal replacement therapy: still relevant?
  per: Honore, Patrick M, et al.
  Publicat: (2015)
• Continuous renal replacement therapy for safe and adequate voriconazole intravenous treatment: enough reason to be confident?
  per: Honore, Patrick M, et al.
  Publicat: (2015)
• Higher colistin dose during continuous renal replacement therapy: look before leaping!
  per: Honore, Patrick M., et al.
  Publicat: (2015)